What's behind Cboe Global Markets's latest 3.4% stock pullback?

Traders Union
All News
Stocks
Cboe global markets slides 3.36% today

Highlights

Cboe Global Markets reported third quarter 2026 net revenue rising 18% year over year to $712 million.
The company extended exclusive S&P 500 Index options licensing through 2051 and confirmed a quarterly dividend.
Shares of Cboe Global Markets last traded at $338.16, with strong momentum signals but short-term selling pressure after a 3.36% decline; the projected five-day trading range is $317.61 to $358.71.

Earnings growth and new deals fail to offset selling pressure

Cboe Global Markets reported third quarter 2026 earnings on October 30, 2026, with net revenue up 18% year-over-year to $712 million. The company extended its exclusive S&P 500 Index options licensing agreement through 2051 and announced the appointment of a new chief human resources officer. A quarterly dividend was confirmed on October 22, 2026, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, notes ongoing volatility in Cboe Global Markets despite bullish signals from technical indicators. He points out that recent selling pressure sharply contradicts the positive earnings momentum and extension of the S&P 500 options deal. Kharitonov warns that the overbought CCI signals a heightened risk of a near-term pullback. He remains cautious about the validity of the uptrend until support at $336.32 is firmly defended. "Traders should be wary, as aggressive intraday selling like this can quickly undermine even the most robust trends."

Viktoras Karapetjanc, expert at Traders Union, sees continued strength in Cboe Global Markets following impressive revenue growth and strategic licensing extensions. He believes fundamentals and resilient technicals set the stage for further upside. Market structure remains bullish despite recent volatility, with upside breakout potential above $351.36. "The market offers multiple bullish setups here — further growth is likely as long as the positive backdrop continues."

Sholanke Dele, market strategist, flags the sharp 3.36% drop in Cboe Global Markets as a sign of growing caution. He observes that even positive earnings and a new leadership appointment failed to offset the bearish sentiment. Dele attributes the volatility to broader risk aversion and warns of downside risk if support fails. "Current sentiment remains fragile, and sustained lows below $336.32 would open the door to further declines."

Bullish momentum remains as volatility raises short-term correction risk

CBOE continues to trade above its 20-day, 50-day, and 200-day moving averages ($313.26, $295.73, $292.94), presenting a bullish outlook across all timeframes. The short-term resistance is at $351.36, with support at $336.32. The bullish trend is further confirmed by a positive spread between the 50-day and 200-day moving averages as well as Ichimoku Kijun support at $302.28. Momentum signals are strong, with both MACD and ADX indicating buying territory. RSI and Stochastic RSI remain neutral, while the Commodity Channel Index (CCI) is in the overbought range, highlighting a potential risk of a short-term correction. Bull/Bear Power points to intraday buyer dominance, although recent selling pressure and 4.47% intraday volatility show active participation from sellers after the market open.

Earlier, analysts noted that U.S. equities faced renewed caution and volatility, with particular focus on market structure and the dynamic between sector rotation and broader selling pressures. The latest technical and fundamental strengths in Cboe Global Markets add a new dimension, highlighting $351.36 as a key level to watch for a sustained bullish breakout in the near term.

Source of Data: CBOE Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.